| Eileena Newton, | |
|
92 Campus Dr, Scarborough, ME 04074-7228 | |
| (078) 831-4142 | |
| Not Available |
| Full Name | Eileena Newton |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 9 Years |
| Location | 92 Campus Dr, Scarborough, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275996407 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Medical Partners | 9335043967 | 789 |
| Mainehealth | 7517860588 | 2067 |
News Archive
Parents should not be worried, that early vaccination would overwhelm their babies. Recent data show, that the immune system of newborns is able to respond to a world full of antigens already at birth.
AIDS Healthcare Foundation today released the results of a groundbreaking online survey designed to gain better understanding of community perceptions regarding the possible use of an HIV prevention pill.
Whether it is related to electronic health records, accountable care, medical homes, meaningful use, or other initiatives to improve patient safety and quality, a healthcare organization's ability to succeed—or fend off competition—depends on its ability to effectively exchange health information within the organization, with outside groups such as physician offices and payers, and with Health Information Exchanges.
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
› Verified 7 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Parents should not be worried, that early vaccination would overwhelm their babies. Recent data show, that the immune system of newborns is able to respond to a world full of antigens already at birth.
AIDS Healthcare Foundation today released the results of a groundbreaking online survey designed to gain better understanding of community perceptions regarding the possible use of an HIV prevention pill.
Whether it is related to electronic health records, accountable care, medical homes, meaningful use, or other initiatives to improve patient safety and quality, a healthcare organization's ability to succeed—or fend off competition—depends on its ability to effectively exchange health information within the organization, with outside groups such as physician offices and payers, and with Health Information Exchanges.
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
› Verified 7 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992719272 PECOS PAC ID: 9335043967 Enrollment ID: O20050901000035 |
News Archive
Parents should not be worried, that early vaccination would overwhelm their babies. Recent data show, that the immune system of newborns is able to respond to a world full of antigens already at birth.
AIDS Healthcare Foundation today released the results of a groundbreaking online survey designed to gain better understanding of community perceptions regarding the possible use of an HIV prevention pill.
Whether it is related to electronic health records, accountable care, medical homes, meaningful use, or other initiatives to improve patient safety and quality, a healthcare organization's ability to succeed—or fend off competition—depends on its ability to effectively exchange health information within the organization, with outside groups such as physician offices and payers, and with Health Information Exchanges.
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eileena Newton, 92 Campus Drive, Scarborough, ME 04074 Ph: (207) 883-1414 | Eileena Newton, 92 Campus Dr, Scarborough, ME 04074-7228 Ph: (078) 831-4142 |
News Archive
Parents should not be worried, that early vaccination would overwhelm their babies. Recent data show, that the immune system of newborns is able to respond to a world full of antigens already at birth.
AIDS Healthcare Foundation today released the results of a groundbreaking online survey designed to gain better understanding of community perceptions regarding the possible use of an HIV prevention pill.
Whether it is related to electronic health records, accountable care, medical homes, meaningful use, or other initiatives to improve patient safety and quality, a healthcare organization's ability to succeed—or fend off competition—depends on its ability to effectively exchange health information within the organization, with outside groups such as physician offices and payers, and with Health Information Exchanges.
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.
› Verified 7 days ago
Dr. Jason Alan Helis, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, Scarborough, ME 04074 Phone: 207-883-1414 | |
Dr. Benjamin James Drapcho, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 92 Campus Dr Fl 2, Scarborough, ME 04074 Phone: 207-883-1414 | |
Peter Y. Kang, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7 Oak Hill Ter Ste 218, Scarborough, ME 04074 Phone: 207-303-0022 Fax: 207-303-0023 | |
Dr. Jacob Morgan Stout, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 92 Campus Dr, Scarborough, ME 04074 Phone: 207-662-0111 | |
John R Belden, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 49 Spring St, 2nd Floor, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1518 | |
Heidi L Henninger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 2nd Floor, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1518 | |
Diana Jeanne Goodman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1010 |